Peer review reports
From: Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors
| Original Submission |
| 28 Apr 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
| Publishing |
| 28 Jul 2016 |
Editorially accepted |
|
| 18 Aug 2016 |
Article published |
10.1186/s12885-016-2642-1
|
Learn about peer review
